1-3
2026
影响因子区间
—
平台估算
16%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.
【译文】近年来,先进的分子研究技术已经改变了血液学。随着对血液疾病理解的提高,我们现在有机会研究并评估新的生物疗法、新药和药物组合、新的治疗方案以及包括干细胞移植在内的新方法。我们还可以期待蛋白质组学、分子遗传学和生物标志物研究将促进新的诊断方法以及适当疗法的识别。关于血细胞和造血组织的形成和功能的进一步知识应该随之而来,对于血液学家来说,采用这些新范式并制定综合策略以定义最佳患者护理将是一个重大挑战。Expert Review of Hematology (1747-4086) 将这些进步置于背景中,并探讨它们如何直接转化为临床实践。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |